Corticobasal degeneration is a rare, progressive brain disease that remains difficult to diagnose accurately.
In short: Corticobasal degeneration is a rare, progressive brain condition that causes nerve cells to die and brain areas to shrink. It typically presents with asymmetric movement issues, such as a limb that feels foreign or uncontrollable, alongside cognitive decline. Because symptoms mimic other disorders, definitive diagnosis often requires post-mortem examination.
Corticobasal degeneration (CBD) is a rare neurodegenerative disease characterized by the accumulation of a protein called tau within brain cells. This buildup triggers the death of nerve cells and the shrinkage of structures like the cerebral cortex and the basal ganglia. While the exact cause of these tau clumps remains unclear, researchers have identified potential genetic links, including variants on chromosome 17, such as the H1 haplotype, and genes like MAPT and MOBP. Despite these findings, the condition is rarely hereditary, and lifestyle or environmental factors do not appear to influence its development.
The clinical manifestation of CBD, often termed corticobasal syndrome (CBS), is highly variable. Patients typically experience symptoms between the ages of 50 and 70, with an average onset around age 64. Early signs often involve asymmetric motor dysfunction, such as stiffness, tremors, or 'alien hand syndrome,' where a limb seems to move independently or resist control. Cognitive and behavioral changes—including executive function deficits, aphasia, and apathy—may also emerge, sometimes preceding motor symptoms. Because these signs overlap with conditions like Parkinson's disease, progressive supranuclear palsy, and Alzheimer's disease, clinicians must rely on symptom patterns and brain scans to rule out other causes.
As the disease progresses, symptoms gradually worsen, eventually impacting balance, speech, and the ability to swallow. These complications, particularly difficulty swallowing, significantly increase the risk of life-threatening issues like pneumonia, choking, and sepsis. While there is no cure, multidisciplinary care involving neurologists, physiotherapists, and speech therapists can help manage symptoms and improve quality of life. Life expectancy for those with confirmed CBD typically ranges from 2 to 12 years, with an average of 6 to 8 years from the onset of symptoms.
The diagnostic challenge is significant because no single test confirms CBD during a patient's life. Neurologists must synthesize clinical observations, often noting that symptoms like bradykinesia or apraxia—the inability to perform learned tasks—become more pronounced over time. Because the disease is progressive and affects the brain's information processing and movement centers, early planning and supportive care are essential for managing the long-term trajectory of the illness.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Corticobasal degeneration - Symptoms and causes
- Also: Corticobasal degeneration
- Also: Corticobasal Degeneration (Corticobasal Syndrome)
- Also: Corticobasal degeneration
To cite this card, link to https://intellectplus.co.uk/app/science-corticobasal-degeneration.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Human body & genes · More in Science · Latest · A–Z · All topics